Literature DB >> 23731633

Overdiagnosing early spondyloarthritis: what are the risks?

Jean-Marie Berthelot1, Benoît Le Goff, Yves Maugars.   

Abstract

Entities:  

Keywords:  ASAS; Adalimumab; Ankylosing spondylitis; Infraradiological; New York criteria; Spondyloarthritis; TNFα antagonists

Mesh：

Substances：

Year:  2013        PMID： 23731633     DOI： 10.1016/j.jbspin.2013.04.010

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN： 1297-319X            Impact factor:   4.929


× No keyword cloud information.
  2 in total

1.  Comment on "treat-to-target in spondyloarthritis: implications for clinical trial designs".

Authors:  Daniel Wendling; Clément Prati
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

Review 2.  Sacroiliac joint beyond sacroiliitis-further insights and old concepts on magnetic resonance imaging.

Authors:  Bruno Cerretti Carneiro; Thiago Astil Rizzetto; Flávio Duarte Silva; Isabela Azevedo Nicodemos da Cruz; Júlio Brandão Guimarães; Alípio Gomes Ormond Filho; Marcelo Astolfi Caetano Nico
Journal:  Skeletal Radiol       Date:  2022-05-13       Impact factor: 2.128
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.